Former New York mayor and businessman Michael Bloomberg is giving $300 million to the Johns Hopkins University Bloomberg School of Public Health to help fight drug addiction, obesity and gun violence.
The next CONNECTpreneur event is September 28 at the Hyatt Regency Bethesda. More info at connectpreneur.org
There’s a 40% discount code just for eBiz Alert subscribers: Enter CODE: MOCO when you register at http://connectpreneursept2016.eventbrite.com.
This event’s Fireside guest is Seth Goldman, Founder and TeaEO, Honest Tea.
From Mark Suster:
“I recently read a blog post by Beezer Clarkson, Managing Director of Sapphire Ventures about why entrepreneurs should care about from whom their VC funds raise their capital. I spent a bunch of time thinking about this position — especially since Beezer is an investor in Upfront Ventures. There are a lot of things I think entrepreneurs should care about when raising from a VC:”
The 2016 Steering Committee of the Montgomery County Executive Hispanic Gala (MCEHG) announces that Montgomery County Public Schools Assistant Principal Vilma C. Nájera will be the recipient of the “Educator of the Year” Award to be presented during the gala celebration on September 22, 2016 at The Fillmore Silver Spring.
Ms. Vilma C. Nájera is an Assistant Principal at Springbrook High School and one of the county coordinators for the Minority Scholars Program. Through her work last year at Springbrook, there was an increase in the number of Hispanic males graduating. She also launched the Minority Scholars Program at Springbrook.
The Minority Scholars Program, MSP, is a group of student leaders that focuses on closing the achievement gap at their schools and county wide.
IDT Biologika, a globally integrated manufacturer of vaccines and biopharmaceuticals, announces today the one-year anniversary celebration of its first U.S. contract manufacturing facility in Rockville, Maryland. The state-of-the-art facility offers custom, end-to-end solutions to support the manufacture of viral and microbial vaccines (live and attenuated), gene and cancer therapies, and therapeutic proteins. IDT commemorates its first anniversary with a special program and tours of its facility for local political leaders and members of the biopharmaceutical industry.
Tekes – the Finnish Funding Agency for Innovation (Tekes) and IBM (NYSE: IBM) today announced a partnership that will enable Finland to utilize Watson cognitive computing to help doctors improve the health of its citizens, and strengthen and develop the Finnish innovation and business ecosystem in the fields of health and well-being. To facilitate the collaboration, IBM intends to establish a Watson Health Center of Excellence in Finland, the first Nordic Healthcare Competence Center, and the first National Imaging Center of Excellence outside the United States in Finland. These centers are expected to employ 150 people over the next few years.
At first glance, Moderna Therapeutics looks like the most enviable biotech startup in the world. It has smashed fundraising records and teamed up with pharmaceutical giants as it pursues a radical plan to revolutionize medicine by transforming human cells into drug factories.
But the reality is more complicated.
David Petr, who has been hired to guide economic development in Montgomery County, said the county has what it needs to compete against rival Fairfax County: a quality work force.
“The true benefit of doing business here is the quality of talent,” Petr said Tuesday after a meeting with the Montgomery County Council.
Verily, Alphabet’s life sciences group, is investing big in developing technologies for the millions of people worldwide with diabetes.
Verily announced today that it is teaming up with pharmaceutical giant Sanofi to fund and spin out a new venture, Cambridge, Mass.-based Onduo, which is focused on helping clinicians and their patients manage the disease. The companies have tapped a new CEO to lead the startup, trained emergency-medicine physician Joshua Riff, from United Healthcare-owned Optum.
The University of Maryland School of Medicine tested out its first Zika vaccine shots Tuesday, in hopes to further research that could lead to a vaccine used around the world.
The vaccine was developed by the National Institute of Health, which chose three places to test, first in their labs in Bethesda, then at the U of M School of Medicine, and finally at Emery University in Atlanta.